Sun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 277291.14 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2023, the company has reported a Consolidated Total Income of Rs 12145.28 Crore, up 7.44 % from last quarter Total Income of Rs 11303.95 Crore and up 12.83 % from last year same quarter Total Income of Rs 10763.90 Crore. Company has reported net profit after tax of Rs 2013.04 Crore in latest quarter.
Investment Rationale
Stock has provided a breakout from the falling channel with a bullish crossover on its daily MACD.
Promoter/FII Holdings
Promoters held 54.48 per cent stake in the company as of 30-Jun-2023, while FIIs owned 16.48 per cent, DIIs 19.5 per cent.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price